跳至主要内容
临床试验/NCT05350098
NCT05350098进行中(未招募)不适用

A Randomized Controlled Trial to Evaluate the Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease: a Pilot-study

Osaka University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
2
主要终点
Change in serum levels of indoxyl sulfate, p-Cresyl sulfate and trimethylamine N-Oxide

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of plant-protein diets for 12 weeks in patients with advanced chronic kidney disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with chronic kidney disease who were referred to the Outpatient Department of Nephrology at Osaka University Hospital
  • eGFR < 20 mL/min/1.73 m2
  • taking anigiotensin-converting enzyme inhibitors or angiotensin Ⅱ receptor blockers or angiotensin receptor neprilysin inhibitor
  • K < 5.5 mEq/L

排除标准

  • Being planned to intitate renal replacement therapies within 3 months
  • Having inflammatory bowel diseases
  • History of gastrointestinal tract surgery
  • Taking antibiotics within 1 month before the entry
  • Taking or being planned to start warfarin
  • Having dietary allergies
  • Having difficulty in oral intake
  • During pregnancy or breastfeeding
  • Unsuitable for participant in the trial by an attending physician

结局指标

主要结局

Change in serum levels of indoxyl sulfate, p-Cresyl sulfate and trimethylamine N-Oxide

时间窗: 4 weeks after starting intervention

次要结局

  • Change in eGFR(4 weeks after starting intervention)
  • Change in serum bicarbonete levels(4 weeks after starting intervention)
  • Change in serum levels of acetic acid, propionic acid and butyric acid(4 weeks after starting intervention)
  • Change in urinary citrate to creatinine ratio(4 weeks after starting intervention)
  • Change in blood pressure(4 weeks after starting intervention)
  • Dietary adherence(4 weeks after starting intervention)
  • Diversity and composition of the gut microbiota(4 weeks after starting intervention)
  • Change in muscle mass(4 weeks after starting intervention)
  • Change in urinary protein creatinine ratio(4 weeks after starting intervention)
  • Change in serum levels of calcium, phosphate, intact parathyroid hormone and intact fibroblast growth factor 23(4 weeks after starting intervention)
  • The number of oral medications including antihypertensive drugs, diuretics, potassium tablets, potassium binders, phosphate binders, calcium tablets, active vitamin D3 analogs and sodium bicarbonate(4 weeks after starting intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yusuke Sakaguchi

assistant professor

Osaka University

研究点 (2)

Loading locations...

相似试验